Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Invested Capital (2024)

Historic Return on Invested Capital for Adma Biologics (ADMA) over the last 4 years, with Q3 2025 value amounting to 0.54%.

  • Adma Biologics' Return on Invested Capital rose 300.0% to 0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.9% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Adma Biologics' Return on Invested Capital stood at 0.54%, which was up 300.0% from 0.58% recorded in Q2 2025.
  • Adma Biologics' Return on Invested Capital's 5-year high stood at 0.75% during Q4 2024, with a 5-year trough of 0.37% in Q1 2024.